nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethambutol—Pericarditis—Vandetanib—thyroid cancer	0.0708	0.0708	CcSEcCtD
Ethambutol—Visual acuity reduced—Vandetanib—thyroid cancer	0.0515	0.0515	CcSEcCtD
Ethambutol—Myocarditis—Epirubicin—thyroid cancer	0.0313	0.0313	CcSEcCtD
Ethambutol—Myocarditis—Doxorubicin—thyroid cancer	0.0289	0.0289	CcSEcCtD
Ethambutol—Neutropenia—Vandetanib—thyroid cancer	0.018	0.018	CcSEcCtD
Ethambutol—Pericarditis—Epirubicin—thyroid cancer	0.0177	0.0177	CcSEcCtD
Ethambutol—Pneumonia—Vandetanib—thyroid cancer	0.0172	0.0172	CcSEcCtD
Ethambutol—Hepatic function abnormal—Sorafenib—thyroid cancer	0.0172	0.0172	CcSEcCtD
Ethambutol—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.017	0.017	CcSEcCtD
Ethambutol—Pericarditis—Doxorubicin—thyroid cancer	0.0163	0.0163	CcSEcCtD
Ethambutol—Dermatitis exfoliative—Sorafenib—thyroid cancer	0.0159	0.0159	CcSEcCtD
Ethambutol—Visual impairment—Vandetanib—thyroid cancer	0.0148	0.0148	CcSEcCtD
Ethambutol—Erythema multiforme—Vandetanib—thyroid cancer	0.0145	0.0145	CcSEcCtD
Ethambutol—Blindness—Epirubicin—thyroid cancer	0.0138	0.0138	CcSEcCtD
Ethambutol—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.0135	0.0135	CcSEcCtD
Ethambutol—Blindness—Doxorubicin—thyroid cancer	0.0128	0.0128	CcSEcCtD
Ethambutol—Vision blurred—Vandetanib—thyroid cancer	0.0126	0.0126	CcSEcCtD
Ethambutol—Abdominal discomfort—Sorafenib—thyroid cancer	0.0124	0.0124	CcSEcCtD
Ethambutol—Optic neuritis—Epirubicin—thyroid cancer	0.0124	0.0124	CcSEcCtD
Ethambutol—Neutropenia—Sorafenib—thyroid cancer	0.0121	0.0121	CcSEcCtD
Ethambutol—Pneumonia—Sorafenib—thyroid cancer	0.0116	0.0116	CcSEcCtD
Ethambutol—Optic neuritis—Doxorubicin—thyroid cancer	0.0115	0.0115	CcSEcCtD
Ethambutol—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.0115	0.0115	CcSEcCtD
Ethambutol—Arthralgia—Vandetanib—thyroid cancer	0.0114	0.0114	CcSEcCtD
Ethambutol—Neuropathy peripheral—Sorafenib—thyroid cancer	0.0113	0.0113	CcSEcCtD
Ethambutol—Thrombocytopenia—Vandetanib—thyroid cancer	0.0107	0.0107	CcSEcCtD
Ethambutol—Neuritis—Epirubicin—thyroid cancer	0.0102	0.0102	CcSEcCtD
Ethambutol—Scotoma—Epirubicin—thyroid cancer	0.0101	0.0101	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00996	0.00996	CcSEcCtD
Ethambutol—Paraesthesia—Vandetanib—thyroid cancer	0.00981	0.00981	CcSEcCtD
Ethambutol—Erythema multiforme—Sorafenib—thyroid cancer	0.00981	0.00981	CcSEcCtD
Ethambutol—Decreased appetite—Vandetanib—thyroid cancer	0.0095	0.0095	CcSEcCtD
Ethambutol—Neuritis—Doxorubicin—thyroid cancer	0.00946	0.00946	CcSEcCtD
Ethambutol—Scotoma—Doxorubicin—thyroid cancer	0.00931	0.00931	CcSEcCtD
Ethambutol—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00894	0.00894	CcSEcCtD
Ethambutol—Body temperature increased—Vandetanib—thyroid cancer	0.00864	0.00864	CcSEcCtD
Ethambutol—Abdominal pain—Vandetanib—thyroid cancer	0.00864	0.00864	CcSEcCtD
Ethambutol—Leukopenia—Sorafenib—thyroid cancer	0.00809	0.00809	CcSEcCtD
Ethambutol—Pruritus—Vandetanib—thyroid cancer	0.00773	0.00773	CcSEcCtD
Ethambutol—Arthralgia—Sorafenib—thyroid cancer	0.00769	0.00769	CcSEcCtD
Ethambutol—Anaphylactic shock—Sorafenib—thyroid cancer	0.00737	0.00737	CcSEcCtD
Ethambutol—Dizziness—Vandetanib—thyroid cancer	0.00723	0.00723	CcSEcCtD
Ethambutol—Thrombocytopenia—Sorafenib—thyroid cancer	0.00722	0.00722	CcSEcCtD
Ethambutol—Anorexia—Sorafenib—thyroid cancer	0.00703	0.00703	CcSEcCtD
Ethambutol—Vomiting—Vandetanib—thyroid cancer	0.00695	0.00695	CcSEcCtD
Ethambutol—Rash—Vandetanib—thyroid cancer	0.00689	0.00689	CcSEcCtD
Ethambutol—Dermatitis—Vandetanib—thyroid cancer	0.00688	0.00688	CcSEcCtD
Ethambutol—Headache—Vandetanib—thyroid cancer	0.00685	0.00685	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00672	0.00672	CcSEcCtD
Ethambutol—Lymphadenopathy—Epirubicin—thyroid cancer	0.0065	0.0065	CcSEcCtD
Ethambutol—Nausea—Vandetanib—thyroid cancer	0.00649	0.00649	CcSEcCtD
Ethambutol—Decreased appetite—Sorafenib—thyroid cancer	0.00641	0.00641	CcSEcCtD
Ethambutol—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00634	0.00634	CcSEcCtD
Ethambutol—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00603	0.00603	CcSEcCtD
Ethambutol—Lymphadenopathy—Doxorubicin—thyroid cancer	0.00601	0.00601	CcSEcCtD
Ethambutol—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.00588	0.00588	CcSEcCtD
Ethambutol—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.00587	0.00587	CcSEcCtD
Ethambutol—Abdominal pain—Sorafenib—thyroid cancer	0.00583	0.00583	CcSEcCtD
Ethambutol—Body temperature increased—Sorafenib—thyroid cancer	0.00583	0.00583	CcSEcCtD
Ethambutol—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.00573	0.00573	CcSEcCtD
Ethambutol—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.00544	0.00544	CcSEcCtD
Ethambutol—Hypersensitivity—Sorafenib—thyroid cancer	0.00543	0.00543	CcSEcCtD
Ethambutol—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.0053	0.0053	CcSEcCtD
Ethambutol—Pruritus—Sorafenib—thyroid cancer	0.00522	0.00522	CcSEcCtD
Ethambutol—Liver function test abnormal—Epirubicin—thyroid cancer	0.00512	0.00512	CcSEcCtD
Ethambutol—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00499	0.00499	CcSEcCtD
Ethambutol—Dizziness—Sorafenib—thyroid cancer	0.00488	0.00488	CcSEcCtD
Ethambutol—Eosinophilia—Epirubicin—thyroid cancer	0.00474	0.00474	CcSEcCtD
Ethambutol—Liver function test abnormal—Doxorubicin—thyroid cancer	0.00474	0.00474	CcSEcCtD
Ethambutol—Vomiting—Sorafenib—thyroid cancer	0.00469	0.00469	CcSEcCtD
Ethambutol—Rash—Sorafenib—thyroid cancer	0.00465	0.00465	CcSEcCtD
Ethambutol—Dermatitis—Sorafenib—thyroid cancer	0.00464	0.00464	CcSEcCtD
Ethambutol—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00462	0.00462	CcSEcCtD
Ethambutol—Headache—Sorafenib—thyroid cancer	0.00462	0.00462	CcSEcCtD
Ethambutol—Neutropenia—Epirubicin—thyroid cancer	0.00448	0.00448	CcSEcCtD
Ethambutol—Eosinophilia—Doxorubicin—thyroid cancer	0.00439	0.00439	CcSEcCtD
Ethambutol—Nausea—Sorafenib—thyroid cancer	0.00438	0.00438	CcSEcCtD
Ethambutol—Pneumonia—Epirubicin—thyroid cancer	0.0043	0.0043	CcSEcCtD
Ethambutol—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00424	0.00424	CcSEcCtD
Ethambutol—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00419	0.00419	CcSEcCtD
Ethambutol—Neutropenia—Doxorubicin—thyroid cancer	0.00415	0.00415	CcSEcCtD
Ethambutol—Pneumonia—Doxorubicin—thyroid cancer	0.00398	0.00398	CcSEcCtD
Ethambutol—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.00392	0.00392	CcSEcCtD
Ethambutol—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00387	0.00387	CcSEcCtD
Ethambutol—Hepatitis—Epirubicin—thyroid cancer	0.00384	0.00384	CcSEcCtD
Ethambutol—Hypoaesthesia—Epirubicin—thyroid cancer	0.00382	0.00382	CcSEcCtD
Ethambutol—Visual impairment—Epirubicin—thyroid cancer	0.0037	0.0037	CcSEcCtD
Ethambutol—Erythema multiforme—Epirubicin—thyroid cancer	0.00363	0.00363	CcSEcCtD
Ethambutol—Hepatitis—Doxorubicin—thyroid cancer	0.00355	0.00355	CcSEcCtD
Ethambutol—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00353	0.00353	CcSEcCtD
Ethambutol—Visual impairment—Doxorubicin—thyroid cancer	0.00342	0.00342	CcSEcCtD
Ethambutol—Erythema multiforme—Doxorubicin—thyroid cancer	0.00336	0.00336	CcSEcCtD
Ethambutol—Vision blurred—Epirubicin—thyroid cancer	0.00315	0.00315	CcSEcCtD
Ethambutol—Ill-defined disorder—Epirubicin—thyroid cancer	0.0031	0.0031	CcSEcCtD
Ethambutol—Malaise—Epirubicin—thyroid cancer	0.00301	0.00301	CcSEcCtD
Ethambutol—Leukopenia—Epirubicin—thyroid cancer	0.00299	0.00299	CcSEcCtD
Ethambutol—Vision blurred—Doxorubicin—thyroid cancer	0.00291	0.00291	CcSEcCtD
Ethambutol—Ill-defined disorder—Doxorubicin—thyroid cancer	0.00287	0.00287	CcSEcCtD
Ethambutol—Arthralgia—Epirubicin—thyroid cancer	0.00284	0.00284	CcSEcCtD
Ethambutol—Discomfort—Epirubicin—thyroid cancer	0.00281	0.00281	CcSEcCtD
Ethambutol—Malaise—Doxorubicin—thyroid cancer	0.00279	0.00279	CcSEcCtD
Ethambutol—Leukopenia—Doxorubicin—thyroid cancer	0.00277	0.00277	CcSEcCtD
Ethambutol—Confusional state—Epirubicin—thyroid cancer	0.00275	0.00275	CcSEcCtD
Ethambutol—Anaphylactic shock—Epirubicin—thyroid cancer	0.00272	0.00272	CcSEcCtD
Ethambutol—Thrombocytopenia—Epirubicin—thyroid cancer	0.00267	0.00267	CcSEcCtD
Ethambutol—Arthralgia—Doxorubicin—thyroid cancer	0.00263	0.00263	CcSEcCtD
Ethambutol—Discomfort—Doxorubicin—thyroid cancer	0.0026	0.0026	CcSEcCtD
Ethambutol—Anorexia—Epirubicin—thyroid cancer	0.0026	0.0026	CcSEcCtD
Ethambutol—Confusional state—Doxorubicin—thyroid cancer	0.00254	0.00254	CcSEcCtD
Ethambutol—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00252	0.00252	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00248	0.00248	CcSEcCtD
Ethambutol—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00247	0.00247	CcSEcCtD
Ethambutol—Paraesthesia—Epirubicin—thyroid cancer	0.00245	0.00245	CcSEcCtD
Ethambutol—Anorexia—Doxorubicin—thyroid cancer	0.0024	0.0024	CcSEcCtD
Ethambutol—Decreased appetite—Epirubicin—thyroid cancer	0.00237	0.00237	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.0023	0.0023	CcSEcCtD
Ethambutol—Paraesthesia—Doxorubicin—thyroid cancer	0.00226	0.00226	CcSEcCtD
Ethambutol—Feeling abnormal—Epirubicin—thyroid cancer	0.00225	0.00225	CcSEcCtD
Ethambutol—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00223	0.00223	CcSEcCtD
Ethambutol—Decreased appetite—Doxorubicin—thyroid cancer	0.00219	0.00219	CcSEcCtD
Ethambutol—Body temperature increased—Epirubicin—thyroid cancer	0.00215	0.00215	CcSEcCtD
Ethambutol—Abdominal pain—Epirubicin—thyroid cancer	0.00215	0.00215	CcSEcCtD
Ethambutol—Feeling abnormal—Doxorubicin—thyroid cancer	0.00208	0.00208	CcSEcCtD
Ethambutol—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00206	0.00206	CcSEcCtD
Ethambutol—Hypersensitivity—Epirubicin—thyroid cancer	0.00201	0.00201	CcSEcCtD
Ethambutol—Body temperature increased—Doxorubicin—thyroid cancer	0.00199	0.00199	CcSEcCtD
Ethambutol—Abdominal pain—Doxorubicin—thyroid cancer	0.00199	0.00199	CcSEcCtD
Ethambutol—Pruritus—Epirubicin—thyroid cancer	0.00193	0.00193	CcSEcCtD
Ethambutol—Hypersensitivity—Doxorubicin—thyroid cancer	0.00186	0.00186	CcSEcCtD
Ethambutol—Dizziness—Epirubicin—thyroid cancer	0.0018	0.0018	CcSEcCtD
Ethambutol—Pruritus—Doxorubicin—thyroid cancer	0.00178	0.00178	CcSEcCtD
Ethambutol—Vomiting—Epirubicin—thyroid cancer	0.00173	0.00173	CcSEcCtD
Ethambutol—Rash—Epirubicin—thyroid cancer	0.00172	0.00172	CcSEcCtD
Ethambutol—Dermatitis—Epirubicin—thyroid cancer	0.00172	0.00172	CcSEcCtD
Ethambutol—Headache—Epirubicin—thyroid cancer	0.00171	0.00171	CcSEcCtD
Ethambutol—Dizziness—Doxorubicin—thyroid cancer	0.00167	0.00167	CcSEcCtD
Ethambutol—Nausea—Epirubicin—thyroid cancer	0.00162	0.00162	CcSEcCtD
Ethambutol—Vomiting—Doxorubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Ethambutol—Rash—Doxorubicin—thyroid cancer	0.00159	0.00159	CcSEcCtD
Ethambutol—Dermatitis—Doxorubicin—thyroid cancer	0.00159	0.00159	CcSEcCtD
Ethambutol—Headache—Doxorubicin—thyroid cancer	0.00158	0.00158	CcSEcCtD
Ethambutol—Nausea—Doxorubicin—thyroid cancer	0.0015	0.0015	CcSEcCtD
